119 related articles for article (PubMed ID: 11258518)
21. Quality control of iodine-131-labeled metaiodobenzylguanidine.
Taşdelen B; Kam E; Asliyuksek H
Nucl Med Commun; 2014 Jan; 35(1):95-8. PubMed ID: 24162836
[TBL] [Abstract][Full Text] [Related]
22. Potential use of iodine-123 metaiodobenzylguanidine radioaerosol as a marker of pulmonary neuroadrenergic function.
Giordano A; Calcagni ML; Rossi B; Fuso L; Accardo D; Valente S; Pistelli R; Franceschini R; Troncone L
Eur J Nucl Med; 1997 Jan; 24(1):52-8. PubMed ID: 9044877
[TBL] [Abstract][Full Text] [Related]
23. Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.
Admiraal WM; Holleman F; Bahler L; Soeters MR; Hoekstra JB; Verberne HJ
J Nucl Med; 2013 Feb; 54(2):208-12. PubMed ID: 23318291
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
25. Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine.
Shulkin BL; Shapiro B; Tobes MC; Shen SW; Wieland DM; Meyers LJ; Lee HT; Petry NA; Sisson JC; Beierwaltes WH
J Nucl Med; 1986 Jul; 27(7):1138-42. PubMed ID: 3723189
[TBL] [Abstract][Full Text] [Related]
26. Effect of specific activity on cardiac uptake of iodine-123-MIBG.
Farahati J; Bier D; Scheubeck M; Lassmann M; Schelper LF; Grelle I; Hanscheid H; Biko J; Graefe KH; Reiners C
J Nucl Med; 1997 Mar; 38(3):447-51. PubMed ID: 9074536
[TBL] [Abstract][Full Text] [Related]
27. Meta-iodobenzylguanidine derivatives containing a second guanidine moiety.
Vaidyanathan G; Shankar S; Affleck DJ; Alston K; Norman J; Welsh P; LeGrand H; Zalutsky MR
Bioorg Med Chem; 2004 Apr; 12(7):1649-56. PubMed ID: 15028258
[TBL] [Abstract][Full Text] [Related]
28. 111In-pentetreotide scintigraphy is superior to 123I-MIBG scintigraphy in the diagnosis and location of chemodectoma.
Muros MA; Llamas-Elvira JM; Rodríguez A; Ramírez A; Gómez M; Arráez MA; Valéncia E; Vílchez R
Nucl Med Commun; 1998 Aug; 19(8):735-42. PubMed ID: 9751927
[TBL] [Abstract][Full Text] [Related]
29. Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology.
Vallabhajosula S; Nikolopoulou A
Semin Nucl Med; 2011 Sep; 41(5):324-33. PubMed ID: 21803182
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
Narita M; Kurihara T
J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
[TBL] [Abstract][Full Text] [Related]
31. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
[TBL] [Abstract][Full Text] [Related]
32. 123I-metaiodobenzylguanidine (MIBG)-positive testicular mass in a neuroblastoma.
Harada A; Makimoto A; Shimojima N; Yuza Y; Hirobe S
Pediatr Int; 2020 Dec; 62(12):1398-1399. PubMed ID: 33270314
[No Abstract] [Full Text] [Related]
33. Intraoperative localization of neuroblastoma in children with 123I- or 125I-radiolabeled metaiodobenzylguanidine.
Martelli H; Ricard M; Larroquet M; Wioland M; Paraf F; Fabre M; Josset P; Helardot PG; Gauthier F; Terrier-Lacombe MJ; Michon J; Hartmann O; Tabone MD; Patte C; Lumbroso J; Gruner M
Surgery; 1998 Jan; 123(1):51-7. PubMed ID: 9457223
[TBL] [Abstract][Full Text] [Related]
34. Use of metaiodobenzylguanidine (MIBG) in pneumology.
Giordano A; Calcagni ML; Rossi B; Rufini V; Fuso L; Valente S; Pistelli R; Franceschini R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):49-54. PubMed ID: 9002749
[TBL] [Abstract][Full Text] [Related]
35. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
[TBL] [Abstract][Full Text] [Related]
36. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
[TBL] [Abstract][Full Text] [Related]
37. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K
Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352
[TBL] [Abstract][Full Text] [Related]
38. 123I metaiodobenzylguanidine (MIBG) scintigraphy of retinoblastoma: preliminary experience.
Bomanji J; Hungerford JL; Kingston JE; Levison DA; Britton KE
Br J Ophthalmol; 1989 Feb; 73(2):146-50. PubMed ID: 2930761
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, radiolabelling and stability of radioiodinated m-iodobenzylguanidine, a review.
Wafelman AR; Konings MC; Hoefnagel CA; Maes RA; Beijnen JH
Appl Radiat Isot; 1994 Oct; 45(10):997-107. PubMed ID: 7994289
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of no-carrier-added meta-[123I]iodobenzylguanidine for myocardial scintigraphy.
Knickmeier M; Matheja P; Wichter T; Schäfers KP; Kies P; Breithardt G; Schober O; Schäfers M
Eur J Nucl Med; 2000 Mar; 27(3):302-7. PubMed ID: 10774882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
